Tag Archives: cancer

UICC’S TECHNICAL FELLOWSHIPS

Application Deadline: 4 June 2026

LOCATION: Multiple Regions

UICC’s Technical Fellowships provide cancer professionals the chance to gain new knowledge, skills, and techniques in cancer control through short learning visits of two weeks to two months’ duration. Transfer of cancer control knowledge, skills, and techniques through international visits of two weeks up to two months.

ELIGIBILITY:

Public health professionals including epidemiologists, health educators, social workers, nutritionists, administrators and other specialised professionals working in the field of cancer control; cancer researchers performing translational, clinical and/or implementation research; clinicians, nurses and pathologists.

Applicants must hold a minimum of a Master’s degree, while qualified medical doctors may be considered in the absence of a higher degree (i.e an MD) if they hold or are within a year of holding a board certification (or equivalent) in a cancer-related specialty, and registered nurses who have an RN qualification are also eligible to apply.

An equivalent one-year’s training qualification in a specialty related to cancer post university degree can be accepted as an equivalent to a Master’s degree, for example training as a cancer registrar.

All candidates should have worked in the field of cancer for at least five years prior to applying.

Medical and PhD students are not eligible to apply.

The 2026 call will have a strong emphasis on public health and the training of health professionals on cost-effective and evidence-based cancer control strategies and interventions relevant to and appropriate to the applicant’s context and the wider health system.

Applicants from French-speaking African countries have the option to apply in French if they planned to visit a French-speaking country. For further details, please visit the Bourse pour l’Afrique Francophone webpage.

Applicants are generally expected to identify and contact potential host supervisors themselves. However, if they are unable to find a host supervisor, they should reach out to fellows@uicc.org for information on the organisations listed below that have expressed interest in hosting Fellows. Representatives from cancer centres or institutions interested in hosting UICC Fellows should contact fellows@uicc.org for more information. 

National Cancer Centre Korea (NCCK), is a Fellowship partner and host that supports applicants wishing to visit it. 

The Christie NHS Foundation Trust, United Kingdom. 

Princess Margaret Cancer Center, Canada is a Fellowship partner and host that supports applicants wishing to visit it. 

Hospital Moinhos de Vento, Brazil

A.C. Camargo Cancer Center, Brazil

King Hussein Cancer Center , Jordan

University of Colorado Cancer Center, United States

Hospital General Universitario de Elche, Spain

Baheya Foundation and Hospitals, Egypt

BENEFIT:

Fellowship award amounts are calculated by UICC based on the fellowship duration and published scales for living costs and economy flight estimates from the home country to the host country. For more information, refer to the application guidelines.

APPLY

2025 LCRF RESEARCH GRANTS ON OVERCOMING RESISTANCE IN LUNG CANCER

Application Deadline: March 3, 2025

LOCATION: USA

In 2025, in partnership with leading patient advocacy organizations, this grant mechanism will focus on furthering the understanding of the development, prevention, and therapy of resistance by supporting projects that seek to identify, characterize, treat or prevent resistance to lung cancer therapies. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies.

ELIGIBILITY:

Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.

Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.

Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.

Applicants are prohibited from applying in more than one of LCRF’s funding tracks in the same cycle.

Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.

Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office (see Inquiries section below) before submitting an application and at least a week before submission deadline.

Ineligible applications and new requests under special circumstances will not be considered after submission deadline

BENEFIT:

The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year). Additional budget requirements and considerations include the following:

Funding from this award may not be used to support institutional indirect / facilities and administrative costs.

The LCRF grant must be the primary source of support for the project. Additional secondary funding (e.g. for core services support) is permitted.

There is no limit on the amount of salary support that may be requested. However, appropriate justification for all budget items is required. Any salary requests in excess of 20% of the total budget must be explicitly justified. Queries related to justification should be sent to LCRF at least a week before submission deadline.

Any equipment costs must be limited and directly applicable to the research project (i.e. large, general equipment costs are not permitted).

Direct patient care costs reimbursable by other sources may not be included.

Travel and publication costs are permitted.

APPLY